Aclarubicin in Single Agent and Combined Chemotherapy of Adult Acute Myeloid Leukemia
The present contribution summarizes the results of treating acute myeloid leukemia (AML) with aclarubicin (ACM) in three consecutive studies. Some of the results have recently been published elsewhere [1–3].
KeywordsToxicity Leukemia Diarrhea Doxorubicin Bilirubin
Unable to display preview. Download preview PDF.